These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17127550)

  • 1. Cocaine withdrawal symptoms predict medication response in cocaine users.
    Sofuoglu M; Poling J; Gonzalez G; Gonsai K; Kosten T
    Am J Drug Alcohol Abuse; 2006; 32(4):617-27. PubMed ID: 17127550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users.
    Sofuoglu M; Dudish-Poulsen S; Poling J; Mooney M; Hatsukami DK
    Addict Behav; 2005 Jul; 30(6):1125-34. PubMed ID: 15925122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study.
    Sofuoglu M; Poling J; Gonzalez G; Gonsai K; Oliveto A; Kosten TR
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):453-60. PubMed ID: 17924779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of cocaine physical dependence subtypes using the DSM-IV in outpatients receiving opioid agonist medication.
    Disney ER; Kidorf M; King VL; Neufeld K; Kolodner K; Brooner RK
    Drug Alcohol Depend; 2005 Jul; 79(1):23-32. PubMed ID: 15943941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms.
    Kampman KM; Volpicelli JR; Alterman AI; Cornish J; O'Brien CP
    Am J Psychiatry; 2000 Dec; 157(12):2052-4. PubMed ID: 11097979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study.
    Gonzalez G; Sevarino K; Sofuoglu M; Poling J; Oliveto A; Gonsai K; George TP; Kosten TR
    Addiction; 2003 Nov; 98(11):1625-32. PubMed ID: 14616189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of cocaine dependence. Intoxication, withdrawal and prevention of relapse].
    Preuss UW; Bahlmann M; Koller G; Soyka M
    Fortschr Neurol Psychiatr; 2000 May; 68(5):224-38. PubMed ID: 10858947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of progesterone treatment on cocaine responses in male and female cocaine users.
    Sofuoglu M; Mitchell E; Kosten TR
    Pharmacol Biochem Behav; 2004 Aug; 78(4):699-705. PubMed ID: 15301924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA.
    Brodie JD; Figueroa E; Dewey SL
    Synapse; 2003 Dec; 50(3):261-5. PubMed ID: 14515344
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.
    Brodie JD; Figueroa E; Laska EM; Dewey SL
    Synapse; 2005 Feb; 55(2):122-5. PubMed ID: 15543630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome predictors for cocaine dependence.
    Poling J; Kosten TR; Sofuoglu M
    Am J Drug Alcohol Abuse; 2007; 33(2):191-206. PubMed ID: 17497542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting cocaine group treatment outcome in cocaine-abusing methadone patients.
    Tzilos GK; Rhodes GL; Ledgerwood DM; Greenwald MK
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):320-5. PubMed ID: 19803631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients.
    Oliveto A; Poling J; Sevarino KA; Gonsai KR; McCance-Katz EF; Stine SM; Kosten TR
    Drug Alcohol Depend; 2005 Aug; 79(2):157-65. PubMed ID: 16002025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to the treatment of cocaine addiction.
    Sofuoglu M; Kosten TR
    CNS Drugs; 2005; 19(1):13-25. PubMed ID: 15651902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
    Winhusen T; Somoza E; Ciraulo DA; Harrer JM; Goldsmith RJ; Grabowski J; Coleman FS; Mindrum G; Kahn R; Osman S; Mezinskis J; Li SH; Lewis D; Horn P; Montgomery MA; Elkashef A
    Drug Alcohol Depend; 2007 Dec; 91(2-3):141-8. PubMed ID: 17629631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New medications for the treatment of cocaine dependence.
    Kampman KM
    Ann Ist Super Sanita; 2009; 45(2):109-15. PubMed ID: 19636162
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications.
    Coskun O; Ucler S; Cavdar L; Inan LE
    J Clin Neurosci; 2007 Apr; 14(4):334-9. PubMed ID: 16647854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amantadine treatment for cocaine-dependent patients with severe withdrawal symptoms.
    Kampman KM
    Expert Rev Neurother; 2002 Sep; 2(5):601-8. PubMed ID: 19810974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSM-IV criteria endorsement patterns in alcohol dependence: relationship to severity.
    Moss HB; Chen CM; Yi HY
    Alcohol Clin Exp Res; 2008 Feb; 32(2):306-13. PubMed ID: 18162067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.